Canada markets open in 8 hours 55 minutes

ProQR Therapeutics N.V. (PRQR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9200-0.0200 (-1.03%)
At close: 04:00PM EDT
1.9200 0.00 (0.00%)
After hours: 07:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 158.42M
Enterprise Value 67.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)14.03
Price/Book (mrq)4.18
Enterprise Value/Revenue 6.04
Enterprise Value/EBITDA -2.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52-Week Change 33.23%
S&P500 52-Week Change 328.04%
52 Week High 33.2900
52 Week Low 31.1100
50-Day Moving Average 32.1267
200-Day Moving Average 31.8089

Share Statistics

Avg Vol (3 month) 3163.4k
Avg Vol (10 day) 391.51k
Shares Outstanding 581.66M
Implied Shares Outstanding 682.51M
Float 857.8M
% Held by Insiders 118.87%
% Held by Institutions 139.06%
Shares Short (Apr 30, 2024) 4215.28k
Short Ratio (Apr 30, 2024) 41.34
Short % of Float (Apr 30, 2024) 40.37%
Short % of Shares Outstanding (Apr 30, 2024) 40.26%
Shares Short (prior month Mar 28, 2024) 4261.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -254.28%
Operating Margin (ttm)-173.28%

Management Effectiveness

Return on Assets (ttm)-14.85%
Return on Equity (ttm)-56.75%

Income Statement

Revenue (ttm)10.56M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)568.60%
Gross Profit (ttm)N/A
EBITDA -32.65M
Net Income Avi to Common (ttm)-26.84M
Diluted EPS (ttm)-0.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.71M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)19.23M
Total Debt/Equity (mrq)55.21%
Current Ratio (mrq)3.11
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-38.31M
Levered Free Cash Flow (ttm)3.72M